ArticleCancer chemotherapy and pharmacology2020

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.

Ou Yamaguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.